+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Organs-on-Chips - Global Strategic Business Report

  • PDF Icon

    Report

  • 179 Pages
  • March 2024
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 4805906

Global Organs-on-Chips Market to Reach $497.3 Billion by 2030

The global market for Organs-on-Chips estimated at US$44.3 Billion in the year 2022, is projected to reach a revised size of US$497.3 Billion by 2030, growing at a CAGR of 35.3% over the analysis period 2022-2030. Liver, one of the segments analyzed in the report, is projected to record 36.7% CAGR and reach US$186.3 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Kidney segment is readjusted to a revised 37.4% CAGR for the next 8-year period.

The U.S. Market is Estimated at $13.4 Billion, While China is Forecast to Grow at 33.5% CAGR

The Organs-on-Chips market in the U.S. is estimated at US$13.4 Billion in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$79.9 Billion by the year 2030 trailing a CAGR of 33.5% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 32% and 30.1% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 24.5% CAGR.

Select Competitors (Total 12 Featured) -

  • Ascendance Biotechnology, Inc.
  • AxoSim, Inc.
  • CN Bio Innovations Ltd.
  • Emulate, Inc.
  • Hurel Corporation
  • InSphero AG
  • Kirkstall Ltd.
  • Mimetas
  • Nortis, Inc.
  • SynVivo
  • TissUse GmbH

What's New?

  • Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
  • Global competitiveness and key competitor percentage market shares
  • Market presence across multiple geographies - Strong/Active/Niche/Trivial
  • Online interactive peer-to-peer collaborative bespoke updates
  • Access to digital archives and Research Platform
  • Complimentary updates for one year

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Organs-on-Chips - Global Key Competitors Percentage Market Share in 2022 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
  • Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Recent Past, Current & Future Analysis for Organs-on-Chips by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 2: World 8-Year Perspective for Organs-on-Chips by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2023 & 2030
  • Table 3: World Recent Past, Current & Future Analysis for Liver by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 4: World 8-Year Perspective for Liver by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
  • Table 5: World Recent Past, Current & Future Analysis for Kidney by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 6: World 8-Year Perspective for Kidney by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
  • Table 7: World Recent Past, Current & Future Analysis for Lung by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 8: World 8-Year Perspective for Lung by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
  • Table 9: World Recent Past, Current & Future Analysis for Heart by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 10: World 8-Year Perspective for Heart by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
  • Table 11: World Recent Past, Current & Future Analysis for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 12: World 8-Year Perspective for Other Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
  • Table 13: World Recent Past, Current & Future Analysis for Academic & Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 14: World 8-Year Perspective for Academic & Research Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
  • Table 15: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 16: World 8-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
  • Table 17: World Organs-on-Chips Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
  • Table 18: World Recent Past, Current & Future Analysis for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 19: World 8-Year Perspective for Pharma & Biotech Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
  • Table 20: World Recent Past, Current & Future Analysis for Cosmetics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 21: World 8-Year Perspective for Cosmetics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
III. MARKET ANALYSIS
  • UNITED STATES
  • Organs-on-Chips Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
  • Table 22: USA Recent Past, Current & Future Analysis for Organs-on-Chips by Type - Liver, Kidney, Lung, Heart and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 23: USA 8-Year Perspective for Organs-on-Chips by Type - Percentage Breakdown of Value Sales for Liver, Kidney, Lung, Heart and Other Types for the Years 2023 & 2030
  • Table 24: USA Recent Past, Current & Future Analysis for Organs-on-Chips by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Cosmetics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 25: USA 8-Year Perspective for Organs-on-Chips by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes, Cosmetics and Other End-Uses for the Years 2023 & 2030
  • CANADA
  • Table 26: Canada Recent Past, Current & Future Analysis for Organs-on-Chips by Type - Liver, Kidney, Lung, Heart and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 27: Canada 8-Year Perspective for Organs-on-Chips by Type - Percentage Breakdown of Value Sales for Liver, Kidney, Lung, Heart and Other Types for the Years 2023 & 2030
  • Table 28: Canada Recent Past, Current & Future Analysis for Organs-on-Chips by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Cosmetics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 29: Canada 8-Year Perspective for Organs-on-Chips by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes, Cosmetics and Other End-Uses for the Years 2023 & 2030
  • JAPAN
  • Organs-on-Chips Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
  • Table 30: Japan Recent Past, Current & Future Analysis for Organs-on-Chips by Type - Liver, Kidney, Lung, Heart and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 31: Japan 8-Year Perspective for Organs-on-Chips by Type - Percentage Breakdown of Value Sales for Liver, Kidney, Lung, Heart and Other Types for the Years 2023 & 2030
  • Table 32: Japan Recent Past, Current & Future Analysis for Organs-on-Chips by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Cosmetics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 33: Japan 8-Year Perspective for Organs-on-Chips by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes, Cosmetics and Other End-Uses for the Years 2023 & 2030
  • CHINA
  • Organs-on-Chips Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
  • Table 34: China Recent Past, Current & Future Analysis for Organs-on-Chips by Type - Liver, Kidney, Lung, Heart and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 35: China 8-Year Perspective for Organs-on-Chips by Type - Percentage Breakdown of Value Sales for Liver, Kidney, Lung, Heart and Other Types for the Years 2023 & 2030
  • Table 36: China Recent Past, Current & Future Analysis for Organs-on-Chips by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Cosmetics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 37: China 8-Year Perspective for Organs-on-Chips by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes, Cosmetics and Other End-Uses for the Years 2023 & 2030
  • EUROPE
  • Organs-on-Chips Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
  • Table 38: Europe Recent Past, Current & Future Analysis for Organs-on-Chips by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 39: Europe 8-Year Perspective for Organs-on-Chips by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2023 & 2030
  • Table 40: Europe Recent Past, Current & Future Analysis for Organs-on-Chips by Type - Liver, Kidney, Lung, Heart and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 41: Europe 8-Year Perspective for Organs-on-Chips by Type - Percentage Breakdown of Value Sales for Liver, Kidney, Lung, Heart and Other Types for the Years 2023 & 2030
  • Table 42: Europe Recent Past, Current & Future Analysis for Organs-on-Chips by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Cosmetics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 43: Europe 8-Year Perspective for Organs-on-Chips by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes, Cosmetics and Other End-Uses for the Years 2023 & 2030
  • FRANCE
  • Organs-on-Chips Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
  • Table 44: France Recent Past, Current & Future Analysis for Organs-on-Chips by Type - Liver, Kidney, Lung, Heart and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 45: France 8-Year Perspective for Organs-on-Chips by Type - Percentage Breakdown of Value Sales for Liver, Kidney, Lung, Heart and Other Types for the Years 2023 & 2030
  • Table 46: France Recent Past, Current & Future Analysis for Organs-on-Chips by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Cosmetics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 47: France 8-Year Perspective for Organs-on-Chips by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes, Cosmetics and Other End-Uses for the Years 2023 & 2030
  • GERMANY
  • Organs-on-Chips Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
  • Table 48: Germany Recent Past, Current & Future Analysis for Organs-on-Chips by Type - Liver, Kidney, Lung, Heart and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 49: Germany 8-Year Perspective for Organs-on-Chips by Type - Percentage Breakdown of Value Sales for Liver, Kidney, Lung, Heart and Other Types for the Years 2023 & 2030
  • Table 50: Germany Recent Past, Current & Future Analysis for Organs-on-Chips by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Cosmetics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 51: Germany 8-Year Perspective for Organs-on-Chips by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes, Cosmetics and Other End-Uses for the Years 2023 & 2030
  • ITALY
  • Table 52: Italy Recent Past, Current & Future Analysis for Organs-on-Chips by Type - Liver, Kidney, Lung, Heart and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 53: Italy 8-Year Perspective for Organs-on-Chips by Type - Percentage Breakdown of Value Sales for Liver, Kidney, Lung, Heart and Other Types for the Years 2023 & 2030
  • Table 54: Italy Recent Past, Current & Future Analysis for Organs-on-Chips by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Cosmetics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 55: Italy 8-Year Perspective for Organs-on-Chips by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes, Cosmetics and Other End-Uses for the Years 2023 & 2030
  • UNITED KINGDOM
  • Organs-on-Chips Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
  • Table 56: UK Recent Past, Current & Future Analysis for Organs-on-Chips by Type - Liver, Kidney, Lung, Heart and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 57: UK 8-Year Perspective for Organs-on-Chips by Type - Percentage Breakdown of Value Sales for Liver, Kidney, Lung, Heart and Other Types for the Years 2023 & 2030
  • Table 58: UK Recent Past, Current & Future Analysis for Organs-on-Chips by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Cosmetics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 59: UK 8-Year Perspective for Organs-on-Chips by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes, Cosmetics and Other End-Uses for the Years 2023 & 2030
  • REST OF EUROPE
  • Table 60: Rest of Europe Recent Past, Current & Future Analysis for Organs-on-Chips by Type - Liver, Kidney, Lung, Heart and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 61: Rest of Europe 8-Year Perspective for Organs-on-Chips by Type - Percentage Breakdown of Value Sales for Liver, Kidney, Lung, Heart and Other Types for the Years 2023 & 2030
  • Table 62: Rest of Europe Recent Past, Current & Future Analysis for Organs-on-Chips by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Cosmetics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 63: Rest of Europe 8-Year Perspective for Organs-on-Chips by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes, Cosmetics and Other End-Uses for the Years 2023 & 2030
  • ASIA-PACIFIC
  • Organs-on-Chips Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
  • Table 64: Asia-Pacific Recent Past, Current & Future Analysis for Organs-on-Chips by Type - Liver, Kidney, Lung, Heart and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 65: Asia-Pacific 8-Year Perspective for Organs-on-Chips by Type - Percentage Breakdown of Value Sales for Liver, Kidney, Lung, Heart and Other Types for the Years 2023 & 2030
  • Table 66: Asia-Pacific Recent Past, Current & Future Analysis for Organs-on-Chips by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Cosmetics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 67: Asia-Pacific 8-Year Perspective for Organs-on-Chips by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes, Cosmetics and Other End-Uses for the Years 2023 & 2030
  • REST OF WORLD
  • Table 68: Rest of World Recent Past, Current & Future Analysis for Organs-on-Chips by Type - Liver, Kidney, Lung, Heart and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 69: Rest of World 8-Year Perspective for Organs-on-Chips by Type - Percentage Breakdown of Value Sales for Liver, Kidney, Lung, Heart and Other Types for the Years 2023 & 2030
  • Table 70: Rest of World Recent Past, Current & Future Analysis for Organs-on-Chips by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Cosmetics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 71: Rest of World 8-Year Perspective for Organs-on-Chips by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes, Cosmetics and Other End-Uses for the Years 2023 & 2030
IV. COMPETITION

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Ascendance Biotechnology, Inc.
  • AxoSim, Inc.
  • CN Bio Innovations Ltd.
  • Emulate, Inc.
  • Hurel Corporation
  • InSphero AG
  • Kirkstall Ltd.
  • Mimetas
  • Nortis, Inc.
  • SynVivo
  • TissUse GmbH

Table Information